October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 16th 2024
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
October 15th 2024
The conference’s opening keynote sets the scene for 2025 and the years to come.
September 30th 2024
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
Marketing Data Hubs: When Operations and Analytics Collide
How to best plan out and implement a marketing data hub as a key tool to harnessing today’s omnichannel transformation in pharma
Why agility is the key to navigating the fast-changing healthcare landscape
Outlining the key digital trends accelerated by the transformed healthcare landscape in 2021—and their impact on pharma commercialization strategies going forward
Effective patient-first approach in rare disease relies on true sales—not channel stocking
How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings
Maximizing HCP engagement as the definition of a sales ‘call’ expands
How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
Celularity and Arthrex ink exclusive commercial supply and distribution pact
Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine
People, production, and priorities
A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories
Today's hub blueprint: Lock in on the journey
A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
Keeping the message moving during Covid
A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb
Digital is reinventing the critical role of the rep
Covid-19 reveals how important field reps will be to driving digital adoption
Next-gen AI: Widespread adoption hinges on trust
Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Elevating brand outreach in the age of Covid
Using technology to enable processes, drive cost savings, and deliver better patient outcomes
AI ‘voice’ grows louder in 2020
Are regulations hindering pharma innovations?
Patient support in the time of Covid-19
Five ways to adapt manufacturer-sponsored programs
Navigating Covid turbulence: How biopharmas are adapting their go-to-market strategies
Embracing digital channels and patient-centric strategies has been critical for commercial teams; a review of what some companies have done right
HFAP joins ACHC in move that streamlines accreditation and certification services
It marks the first time that two accrediting organizations with deeming authority from CMS have merged
Medical Knowledge Group acquires life sciences market research firm
Plan is to expand capabilities across the drug commercialization process
Omnicell rebrands unit with mission to raise quality at lower cost for providers and payers
EnlivenHealth, formerly Population Health Solutions, targets better patient outcomes through advanced technology
Aktana touts a next-generation form of AI for commercial interactions
'Contextual' AI blends human expertise and computer power
ConnectiveRx invests in HelpAround, a multichannel communications provider, to enhance patient services
A modularized approach will enable pharma marketers to grow patient starts and improve adherence
Digital pills, aka ‘ingestible sensors’, are at a crossroads
Proteus Digital Health, a pioneer, crashes and burns, while EtectRx appoints a new CEO
IQVIA productizes its Ada machine intelligence in orchestrated salesforce management
More complex sales cycles, combined with more digitization of the sales process, calls for better engagement tools
Strategies for effective patient services programs
Addressing continued hurdles in patient adherence
Walgreens takes another stab at retail clinics with VillageMD partnership
Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years
Book review: The Price of Global Health, 3rd edition
Ed Schoonveld’s compilation on pricing strategies gets updated for the 2020s
More Than Ever, New Therapies Require Reimbursement Support
Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges
Kalderos’ 340b management tools will broaden with new funding
Company pitches a mfr-payer-provider-patient collaboration for drug pricing
Get a flash reading of physician sentiment with COVIDPulse
Trinity Life Sciences offers a way to measure changing physician practices during the pandemic
UBC offers ‘intelligent mobile messaging’ in patient support programs
Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction
CMS should reimburse community pharmacists for at-home drug delivery, says NCPA
Position highlights the move toward more at-home services
Planning for the surge: Taking a proactive approach to benefits re-verification season
Use of an eBV system can save months of re-verification work and >$100,000 in operational costs